share_log

Cantor Fitzgerald Reiterates Overweight on Cidara Therapeutics

Benzinga ·  Apr 25 10:32

Cantor Fitzgerald analyst Louise Chen reiterates Cidara Therapeutics (NASDAQ:CDTX) with a Overweight.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment